Visualizing the effect of epigenetic modifications on transcription and mutation
Visualizing the effect of epigenetic modifications on transcription and mutation
批准号:
8663852
负责人:
PETER W LAIRD
金额:
$3.88万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-15 至 2015-03-16
关键词:
Automobile DrivingBackBiochemicalBiologicalBiological AssayBiological ProcessChromatin StructureColorectal CancerComplexCpG dinucleotideCytosineDNA MethylationDNA MethyltransferaseDNA Modification MethylasesDeaminationDevelopmentDiagnosticDiseaseDisease modelEnvironmentEnzymesEpigenetic ProcessEvaluationEventExplosionFluorescenceFrequenciesGene ExpressionGene MutationGeneticGenetic TranscriptionGenomeGenomicsGoalsGreen Fluorescent ProteinsHereditary DiseaseHistonesHumanImageImageryImaging DeviceImaging technologyIn SituIn VitroIndividualKineticsKnowledgeLeadLinkLiteratureMethyltransferaseModificationMonitorMusMutagenesisMutationNatureOpticsPathogenesisPoint MutationProcessProteinsRelative (related person)ReporterRoleS-AdenosylmethionineSignal TransductionSpecificitySystemTechnologyTherapeuticTimeTissuesTranscriptional RegulationVertebratesVisualWorkabstractingcell typechromophoredesignhistone modificationimprovedin vivoin vivo imaginginsightinterestluminescencemutantnovelpreventpromotertooltransition mutation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Histone modification and cytosine-5 DNA methylation represent two important
epigenetic marks. These two very distinct modifications work in close cooperation to control
transcriptional potential, thereby influencing a wide diversity of biological processes. The past
decade has seen an explosion of interest in the role of these epigenetic modifications in
human heath and disease. The goal of the proposed application is to advance our
understanding of these two modifications, by developing and applying two novel in vivo
imaging technologies capable of visualizing the epigenetic and even genetic consequences of
these modifications.
The first specific aim is to develop an in vivo imaging system to assess the causal
influence of individual epigenetic modifications. The technology is designed to both achieve
selective introduction of a desired modification at a predetermined genomic locus, and to
produce a quantitative optical readout of the effect of the epigenetic modification on
transcription. This is achieved through the sequence-specific recruitment of epigenetic modifier
proteins to a promoter driving a fluorescence-luminescence fusion reporter. The power of this
approach comes from the combination of the quantitative optical analysis and the localized
recruitment. This will allow high-throughput evaluation of the primary causal effects of
individual epigenetic modifications.
The second specific aim is to develop an imaging assay for the in vivo visualization of
CpG transition mutations. Transition mutations at the epigenetic DNA methylation mark are
responsible for approximately one-third of all human hereditary disease mutations and for
nearly 50% of all p53 point mutations found in human colorectal cancer. However, the lack of
imaging tools for this type of epigenetically induced mutagenesis has held back our
understanding of the timing and cell-type specificity of this event in vivo. The proposed system
is designed to provide direct visualization of the result of the mutation event. This is achieved
through the use of a mutant green fluorescent protein that produces a fluorescent signal upon
CpG transition mutation in the chromophore region. The conversion of a specific genetic
mutation into an optical signal provides an attractive opportunity to analyze the mutation
without employing direct sequencing. The in situ analysis of mutagenesis would allow us to not
only determine tissue-specific and cell-type specific in vivo CpG mutation frequencies, but also
to analyze mutation kinetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome
-
批准号:10780718
-
项目类别:
-
资助金额:$78.62万
-
财政年份:2023
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10301849
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2021
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10474482
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2021
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10684894
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2021
-
负责人:PETER W LAIRD
-
依托单位:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
-
批准号:10450874
-
项目类别:
-
资助金额:$59.7万
-
财政年份:2020
-
负责人:PETER W LAIRD
-
依托单位:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
-
批准号:10672187
-
项目类别:
-
资助金额:$59.7万
-
财政年份:2020
-
负责人:PETER W LAIRD
-
依托单位:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
-
批准号:10266860
-
项目类别:
-
资助金额:$59.7万
-
财政年份:2020
-
负责人:PETER W LAIRD
-
依托单位:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
-
批准号:10307617
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2018
-
负责人:PETER W LAIRD
-
依托单位:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
-
批准号:10533777
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2018
-
负责人:PETER W LAIRD
-
依托单位:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
-
批准号:10064579
-
项目类别:
-
资助金额:$71.52万
-
财政年份:2018
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10005291
-
项目类别:
-
资助金额:$50.45万
-
财政年份:2016
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8450761
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8625273
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8297718
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8795305
-
项目类别:
-
资助金额:$2.51万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8527891
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8635426
-
项目类别:
-
资助金额:$7.77万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
Visualizing the effect of epigenetic modifications on transcription and mutation
-
批准号:8470607
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2010
-
负责人:PETER W LAIRD
-
依托单位:
Visualizing the effect of epigenetic modifications on transcription and mutation
-
批准号:8137285
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2010
-
负责人:PETER W LAIRD
-
依托单位:
Visualizing the effect of epigenetic modifications on transcription and mutation
-
批准号:9055433
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2010
-
负责人:PETER W LAIRD
-
依托单位:
国内基金
海外基金
患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
-
批准号:2026JJ81464
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:叶婷
-
依托单位:
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
-
批准号:2024KP61
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:余丹
-
依托单位:
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
-
批准号:51307073
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2013
-
负责人:郭兴龙
-
依托单位: